Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,590 GBX | -1.27% | -1.91% | +9.64% |
Apr. 17 | GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix | MT |
Apr. 17 | GSK: positive clinical results for gonorrhea | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.64% | 81.83B | |
+28.79% | 673B | |
+24.81% | 551B | |
-7.64% | 348B | |
+15.00% | 317B | |
+5.99% | 288B | |
+2.47% | 210B | |
-0.02% | 204B | |
-9.98% | 195B | |
-11.71% | 145B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GlaxoSmithKline : iTeos Signs Cancer Drug Development Deal That Could Potentially Bring $2 Billion